Safety Study of a Radiolabeled Antibody (7E11) in Patients With Progressive Hormone Refractory Prostate Cancer

Clinical trial NCT00441571 · UNKNOWN

Trial details

NCT number: NCT00441571
Sponsor: Cytogen Corporation
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Prostate Cancer

Start date: 2007-02-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.